Other peptide-based medications are widely used for conditions like diabetes, multiple sclerosis, and cancer
Am J Pathol 165:18271837 Geurts JJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis
Due to its dual-peptide profile, it is frequently examined in structured investigations focusing on signalling pathway interaction, recovery-response dynamics, and peptide stability within controlled research environments
CLINICAL GUIDE: CANDIDA ESOPHAGITIS Classic Appearance: "Cottage cheese-like" white plaques Multiple confluent, protuberant lesions Yellowish-white appearance Key Clinical Points: Common in immunocompromised patients Presents with dysphagia ("food sticking") Distinguished from odynophagia (pain on swallowing) Management Approach: Empiric fluconazole trial appropriate in right setting If no improvement in 1 week Endoscopy + biopsy Duration: typically 7 days Candida Esophagitis Clinical Guide: Symptoms and Treatment CLINICAL GUIDE: CANDIDA ESOPHAGITIS Classic Appearance: "Cottage cheese-like" white plaques Multiple confluent, protuberant lesions Yellowish-white appearance Key Clinical Points: Common in immunocompromised patients Presents with dysphagia ("food sticking") Distinguished from odynophagia (pain on swallowing) Management Approach: Empiric fluconazole trial appropriate in right setting If no improvement in 1 week Endoscopy + biopsy Duration: typically 7 days To view or add a comment, sign in More Relevant Posts Great insights from Lisa Cassileth MD, FACS on the rise in popularity of Peptide Treatments and the role they play in recovery
While BPC-157 is studied for general gut health, its unknown if it would mitigate specific side effects of GLP-1s like nausea or slowed gastric emptying
One more question to answer
